State CT
Clinical Trials in Connecticut
Recruiting clinical trials with at least one study location in Connecticut. Data updated daily from ClinicalTrials.gov.
Top Conditions in Connecticut
NCT06914596 N/A
Recruiting
A Clinical Trial Comparing Overnight and 2x/Day for 30-minutes Use of the Emanat...
Condition
Periodontitis (Stage 3)
Enrollment
111 pts
Location
United States
Sponsor
McGuire Institute
NCT01193075 N/A
Recruiting
Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT...
Condition
Charcot Marie Tooth Disease
Enrollment
5,000 pts
Location
United States, Australia, Canada
Sponsor
Michael Shy
NCT06321302 Phase 2
Recruiting
A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diab...
Condition
Diabetic Retinopathy
Enrollment
178 pts
Location
United States, Germany, Hungary
Sponsor
Boehringer Ingelheim
NCT07018700 Phase 3
Recruiting
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preve...
Condition
Episodic Migraine
Enrollment
990 pts
Location
United States, Austria, Czechia
Sponsor
Merz Therapeutics GmbH
NCT06006000 N/A
Recruiting
Evaluating the Unmet Needs of Older Adults to Promote Functional Recovery After ...
Condition
Critical Illness
Enrollment
650 pts
Location
United States
Sponsor
Yale University
NCT05642572 Phase 2
Recruiting
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer...
Condition
Recurrent Lung Non-Small Cell Carcinoma
Enrollment
66 pts
Location
United States
Sponsor
SWOG Cancer Research Network
NCT06058039 Phase 3
Recruiting
Study to Assess the Effects of Oral NMRA-335140 in Participants With Major Depre...
Condition
Major Depressive Disorder
Enrollment
332 pts
Location
United States, Bulgaria, Czechia
Sponsor
Neumora Therapeutics, Inc.
NCT04775537 N/A
Recruiting
OssiMend BA in Posterolateral Instrumented Lumbar Fusion
Condition
Spinal Disease
Enrollment
120 pts
Location
United States
Sponsor
Collagen Matrix
NCT05164172 Phase 3
Recruiting
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chroni...
Condition
Migraine
Enrollment
600 pts
Location
United States, Argentina, Canada
Sponsor
H. Lundbeck A/S
NCT05997381 N/A
Recruiting
BioBrace® Implant for Arthroscopic Repair of Full Thickness Rotator Cuff Tears
Condition
Rotator Cuff Tears
Enrollment
268 pts
Location
United States
Sponsor
CONMED Corporation
NCT04166409 Phase 3
Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients Wit...
Condition
Low Grade Astrocytoma
Enrollment
170 pts
Location
United States, Canada, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT06486428 N/A
Recruiting
Small Cell Lung Cancer Community Engagement to Eliminate Research Discepancies
Condition
Small-cell Lung Cancer
Enrollment
30 pts
Location
United States
Sponsor
Addario Lung Cancer Medical In
NCT05050136 Phase 2
Recruiting
A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixib...
Condition
Primary Biliary Cholangitis
Enrollment
260 pts
Location
United States, Argentina, Belgium
Sponsor
Mirum Pharmaceuticals, Inc.
NCT07276399 Phase 3
Recruiting
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared Wit...
Condition
Squamous Cell Carcinoma of Head and Neck
Enrollment
500 pts
Location
United States, Australia, Austria
Sponsor
Janssen Research & Development
NCT07258511 Phase 3
Recruiting
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 ...
Condition
Multiple Myeloma
Enrollment
400 pts
Location
United States, Australia, Brazil
Sponsor
Janssen Research & Development
NCT04044534 Phase 2
Recruiting
Intranasal Insulin for Posttraumatic Stress Disorder
Condition
PTSD
Enrollment
20 pts
Location
United States
Sponsor
VA Connecticut Healthcare Syst
NCT07207811 Phase 3
Recruiting
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine...
Condition
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Enrollment
1,280 pts
Location
United States, Argentina, Australia
Sponsor
Novo Nordisk A/S
NCT06841354 Phase 3
Recruiting
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Comb...
Condition
Triple Negative Breast Neoplasms
Enrollment
1,000 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT06203600 Phase 2, Phase 3
Recruiting
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophage...
Condition
Advanced Esophageal Adenocarcinoma
Enrollment
224 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT03011541 N/A
Recruiting
Stem Cell Ophthalmology Treatment Study II
Condition
Retinal Disease
Enrollment
500 pts
Location
United States, Austria, United Arab Emirates
Sponsor
MD Stem Cells
NCT06171412 N/A
Recruiting
Glu-COACH: a Peer-mentoring Intervention to Reduce Disparities in Continuous Glu...
Condition
Type 1 Diabetes
Enrollment
38 pts
Location
United States
Sponsor
Yale University
NCT05917522 Phase 2
Recruiting
Assessment of Biomarker-Guided CNI Substitution In Kidney Transplantation
Condition
Kidney Transplant
Enrollment
800 pts
Location
United States
Sponsor
National Institute of Allergy
NCT06130553 Phase 1, Phase 2
Recruiting
A Study of AZD3470, a PRMT5 Inhibitor, in Patients With MTAP Deficient Advanced/...
Condition
Advanced Solid Tumors That Are MTAP Deficient
Enrollment
234 pts
Location
United States, Australia, China
Sponsor
AstraZeneca
NCT07040566 Phase 2
Recruiting
A Trial of Varenicline for E-cigarette Cessation
Condition
E-cigarette Use
Enrollment
326 pts
Location
United States
Sponsor
Yale University
NCT06533631 N/A
Recruiting
Measuring Brain Health Using Low-Field Portable MRI
Condition
White Matter Hyperintensity
Enrollment
100 pts
Location
United States
Sponsor
Yale University